Merck Index
From Wikipedia, the free encyclopedia
The Merck Index is an encyclopedia of chemicals, drugs and biologicals with over 10,000 monographs on single substances or groups of related compounds. It also includes an appendix with monographs on organic name reactions. It is published by the United States pharmaceutical company Merck & Co. The Merck Index is also available by subscription in an electronic searchable form, commonly carried by research libraries, as well as in a web-accessible form.
The current edition is the 14th, released in October 2006.
[edit] Past editions
- 13th (2001)
- 12th (1996)
- 11th (1989), ISBN 0-911910-28-X
- 10th (1983)
- 9th (1976)
- 8th (1968)
- 7th (1960)
- 6th (1952)
- 5th (1940)
- 4th (1930)
- 3rd (1907)
- 2nd (1896)
- 1st (1889)
[edit] External links
Merck & Co., Inc. |
---|
Corporate Directors: Lawrence Bossidy | William Bowen | Richard Clark | Johnnetta Cole | William Harrison | William Kelley | Rochelle Lazarus | Thomas Shenk | Anne Tatlock | Samuel Thier | Wendell Weeks | Peter Wendell |
Key products: Indinavir | Aprepitant | Alendronate | Rizatriptan | Finasteride | Montelukast | Rofecoxib | Ezetimibe/simvastatin | Ezetimibe | Simvastatin | The Merck Index | The Merck Manual |
Annual Revenue: $22.9 billion USD (2% FY 2004) | Employees: 63,000 | Stock Symbol: NYSE: MRK | Website: www.merck.com |